Vaccination In Pregnancy Gene Signature: VIP Signature Study

The Optimal Timing of Vaccination in Pregnancy

NCT06466629 ·Status: RECRUITING

Gambia Pertussis Study (GaPs)

NCT03606096 ·Status: UNKNOWN ·Phase: PHASE4

Knowledge of Pregnant Women Concerning Pertussis, Vaccination Against Pertussis and Cocooning Strategy

NCT06114160 ·Status: NOT_YET_RECRUITING

Vaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy in Thailand

NCT02408926 ·Status: COMPLETED ·Phase: PHASE4

GriCoVax Study in 4 Maternity Wards in the Ile-de-France Region

NCT04494581 ·Status: COMPLETED

Boostrix® Pregnancy Registry

NCT02096276 ·Status: COMPLETED

Pertussis Vaccination in Pregnant Women

NCT03909126 ·Status: COMPLETED ·Phase: PHASE4

Peri-conceptional or Pregnancy Exposure of Vaccination and the Risk of Adverse Pregnancy Outcomes

NCT06180447 ·Status: ACTIVE_NOT_RECRUITING

Optimising Protection for Pregnant Women and Infants With Maternal Vaccination

NCT03457194 ·Status: ACTIVE_NOT_RECRUITING

Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.

NCT02569879 ·Status: COMPLETED

Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United States

NCT03973905 ·Status: COMPLETED

First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine

NCT01188512 ·Status: COMPLETED ·Phase: PHASE1

Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine

NCT02453048 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity and Safety of GBS-NN/NN2 in Pregnant Women

NCT05154578 ·Status: COMPLETED ·Phase: PHASE2

Adenovirus Vaccine Pregnancy Registry

NCT01584037 ·Status: WITHDRAWN

Safety and Immunogenicity of 2 Doses Versus 1 Dose of Acellular Pertussis Vaccines Containing Genetically-detoxified Pertussis Toxin in Young Adults Previously Primed With Acellular Pertussis Vaccines

NCT05193734 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

A Follow-up Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Dose) or Controls From Previous RSV MAT Studies During Any Pregnancy Conceived Post Vaccination/Control

NCT05705440 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess Maternal and Infant Outcomes Following Exposure to SPIKEVAX During Pregnancy

NCT06369272 ·Status: COMPLETED

Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib Vaccine

NCT00289796 ·Status: COMPLETED ·Phase: PHASE2

A Study on the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers

NCT04980391 ·Status: TERMINATED ·Phase: PHASE3

A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respiratory Tract Infection When the Pregnant Woman Receives the Approved RSV Vaccine Compared to a Placebo.

NCT06955728 ·Status: RECRUITING ·Phase: PHASE3

Rubella Susceptibility in Multiparous Women

NCT00401505 ·Status: COMPLETED

Study to Assess the Safety & Reactogenicity of GSK Biologicals' DTPa/Hib Vaccine When Given at 3, 4 and 5 Months of Age

NCT00379977 ·Status: COMPLETED ·Phase: PHASE3

Rates of Pertussis Disease Among Persons Receiving Pentacel® or Other Pertussis Vaccines

NCT01129362 ·Status: COMPLETED

Safety and Immunogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b

NCT00808392 ·Status: COMPLETED ·Phase: PHASE3